June 26, 2020 Rare diseases dominate catalysts for the smallest companies Our final look at third-quarter events focuses this time on the smallest players, with data from Amryt, Ovid, Bellus and more.
April 12, 2017 First-quarter floats see haves pulling away from the have-nots Demand for new issues remains sluggish - only eight private biotechs managed to pull off an IPO in the first quarter of 2017.
